PSI Presents: Buprenorphine for Withdrawal Treatment in Acute Care Settings

Thursday, September 16, 2021, 12:00 AM - Wednesday, August 31, 2022, 12:00 AM, Online

As overdose deaths continue to rise, it is more urgent than ever to increase low barrier access points for life-saving treatment for opioid use disorders (OUD). Medications for Addiction Treatment, like buprenorphine, are effective, first-line treatments for OUD, yet stigma, lack of access, federal policies, and other factors make it difficult for people to get care. Starting medications in acute care settings, like urgent care, emergency departments, hospitals, and jails, is one way to increase the impact of treatment where people present for care. In this webinar, Lisa Netherland, MD, will review protocols for rapid access to buprenorphine in acute care settings, including considerations on starting doses, how to decrease the likelihood of precipitated withdrawal, and modifications that may be necessary when fentanyl is involved.

  Release Date: September 16, 2021
  Expiration Date: September 30, 2022
  Estimated Time to Complete: 50 mins
  Registration Fee: FREE

Recorded on February 9, 2021

AMA PRA Category 1 Credits™ (1.00 hours), Non-Physician Participation Credit (1.00 hours)

1. Identify three (3) benefits of providing rapid access to buprenorphine in acute care settings.
2. Determine two (2) factors to consider when establishing a starting dose of buprenorphine in acute care settings.
3. Specify two (2) approaches to decrease the likelihood of precipitated withdrawal.
4. Describe two (2) considerations in starting buprenorphine when a patient has been using fentanyl.
5. Develop strategies to use MAT in acute care settings.

Accreditation
In support of improving patient care, Stanford Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.  

Credit Designation 
American Medical Association (AMA)
Stanford Medicine designates this Enduring Material for a maximum of 1.00 AMA PRA Category 1 Credits^TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Bibliography
Provider Resources: http://www.uclaisap.org/ca-hubandspoke/html/provider-resources.html
https://www.uclaisap.org/oasis-tta/html/resources-toolkits.html
Factsheets and Toolkits: http://uclaisap.org/MATPrescriberSupport/html/factsheets-toolkits.html

Accessibility Statement
 Stanford University School of Medicine is committed to ensuring that its programs, services, goods and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act of 1973 and the Americans with Disabilities Amendments Act of 2008.  If you have needs that require special accommodations, including dietary concerns, please contact the CME Conference Coordinator.

Cultural and Linguistic Competency
The planners and speakers of this CME activity have been encouraged to address cultural issues relevant to their topic area for the purpose of complying with California Assembly Bill 1195. Moreover, the Stanford University School of Medicine Multicultural Health Portal contains many useful cultural and linguistic competency tools including culture guides, language access information and pertinent state and federal laws.  You are encouraged to visit the Multicultural Health Portal: https://laneguides.stanford.edu/multicultural-health

For CME general questions, please contact 
     Email: [email protected]

Mitigation of Relevant Financial Relationships

Stanford Medicine adheres to the Standards for Integrity and Independence in Accredited Continuing Education.

There are no relevant financial relationships with ACCME-defined ineligible companies for anyone who was in control of the content of this activity.